Subscribe
shutterstock_1139644889_martyn_jandula
Martyn Jandula / Shutterstock.com
19 December 2019BiotechnologySarah Morgan

CJEU outlines scope of rights for plant variety owners

The Court of Justice of the European Union (CJEU) has today, December 19, outlined the scope of protection held by owners of plant variety rights in a decision involving a variety of mandarin.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Biotechnology
AG advises CJEU on rights of plant variety owners
19 September 2019   Advocate general Henrik Saugmandsgaard Øe has advised Europe’s highest court on the scope of protection held by owners of plant variety rights.
Big Pharma
CJEU upholds EMA’s right to publish drug firms’ clinical trial data
24 January 2020   The Court of Justice of the European Union has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Biotechnology
AG advises CJEU on rights of plant variety owners
19 September 2019   Advocate general Henrik Saugmandsgaard Øe has advised Europe’s highest court on the scope of protection held by owners of plant variety rights.
Big Pharma
CJEU upholds EMA’s right to publish drug firms’ clinical trial data
24 January 2020   The Court of Justice of the European Union has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.

More on this story

Biotechnology
AG advises CJEU on rights of plant variety owners
19 September 2019   Advocate general Henrik Saugmandsgaard Øe has advised Europe’s highest court on the scope of protection held by owners of plant variety rights.
Big Pharma
CJEU upholds EMA’s right to publish drug firms’ clinical trial data
24 January 2020   The Court of Justice of the European Union has rejected two appeals that would have restricted the European Medicines Agency’s right to publish a pharmaceutical company’s clinical trial data, as it relates to their applications to market their products within the EU.
Africa
Plant breeders facing ‘critical situation’ ask nations for support
9 April 2020   The International Community of Breeders of Asexually Reproduced Ornamental and Fruit Varieties has implored countries to implement support measures for breeders amid the pandemic.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott